HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.

AbstractPURPOSE:
To investigate relationships among vitreous fluid levels of soluble vascular endothelial growth factor receptor-2 (sVEGFR-2), vascular endothelial growth factor (VEGF), and soluble intercellular adhesion molecule 1 (sICAM-1) in patients with branch retinal vein occlusion (BRVO) and macular edema or patients with idiopathic macular hole.
DESIGN:
Retrospective case-control study.
METHODS:
SETTING:
Tokyo Women's Medical University and Eguchi Eye Hospital.
PATIENT POPULATION:
Forty-nine Japanese patients who underwent unilateral vitrectomy (27 with BRVO and 22 with macular hole).
OBSERVATION PROCEDURES:
Vitreous fluid samples were obtained during vitreoretinal surgery to measure the levels of sVEGFR-2, VEGF, and sICAM-1. Retinal ischemia was evaluated from capillary nonperfusion on fluorescein angiography. Macular edema was examined by optical coherence tomography.
MAIN OUTCOME MEASURES:
Vitreous fluid levels of the 3 molecules and severity of macular edema.
RESULTS:
BRVO patients had a significantly higher vitreous fluid level of sVEGFR-2 (median, 1670 pg/mL; interquartile range [IQL], 1205 to 2225 pg/mL) than macular hole patients (median, 1265 pg/mL; IQR, 731 to 1800 pg/mL; P = .017), as was the case for VEGF (median, 237 pg/mL; IQR, 42.2 to 1305 pg/mL; vs median, 15.6 pg/mL; IQR, 15.6 to 15.6 pg/mL; P < .001) and sICAM-1 (median, 10.1 ng/mL; IQR, 6.3 to 22.5 ng/mL; vs median, 4.1 ng/mL; IQR, 3.3 to 6.0 ng/mL; P < .001). In BRVO patients, there was a significant positive correlation between vitreous fluid levels of sVEGFR-2 or VEGF and sICAM-1, but not between sVEGFR-2 and VEGF. Vitreous fluid levels of all 3 molecules were correlated significantly the with severity of macular edema in BRVO patients.
CONCLUSIONS:
sVEGFR-2 may induce an increase of vascular permeability together with or via sICAM-1, or both with and via sICAM-1, in BRVO patients with macular edema.
AuthorsHidetaka Noma, Hideharu Funatsu, Tatsuya Mimura, Shuichiro Eguchi, Sadao Hori
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 152 Issue 4 Pg. 669-677.e1 (Oct 2011) ISSN: 1879-1891 [Electronic] United States
PMID21726846 (Publication Type: Journal Article)
CopyrightCopyright © 2011 Elsevier Inc. All rights reserved.
Chemical References
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Intercellular Adhesion Molecule-1
  • Vascular Endothelial Growth Factor Receptor-2
Topics
  • Aged
  • Case-Control Studies
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Fluorescein Angiography
  • Humans
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Laser Coagulation
  • Macular Edema (diagnosis, metabolism, surgery)
  • Male
  • Retinal Perforations (metabolism)
  • Retinal Vein Occlusion (diagnosis, metabolism)
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Vascular Endothelial Growth Factor A (metabolism)
  • Vascular Endothelial Growth Factor Receptor-2 (metabolism)
  • Vitrectomy
  • Vitreous Body (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: